Relmada Therapeutics shares owned by Parsons Capital Management
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Parsons Capital Management
from 13F filings
Historical chart of Parsons Capital Management investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Parsons Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Relmada Therapeutics by Parsons Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $328k | 163k | 2.01 |
| 2025-06-30 | $98k | 163k | 0.60 |
| 2025-03-31 | $44k | 163k | 0.27 |
| 2024-12-31 | $85k | 163k | 0.52 |
| 2024-09-30 | $3.2M | 1.0M | 3.24 |
| 2024-06-30 | $2.9M | 976k | 3.00 |
| 2024-03-31 | $4.5M | 974k | 4.65 |
| 2023-12-31 | $3.9M | 950k | 4.14 |
| 2023-09-30 | $2.9M | 974k | 3.00 |
| 2023-06-30 | $2.1M | 873k | 2.46 |
| 2023-03-31 | $1.6M | 722k | 2.26 |
| 2022-12-31 | $1.7M | 496k | 3.49 |
| 2022-09-30 | $19M | 504k | 37.02 |
| 2022-06-30 | $9.6M | 504k | 18.99 |
| 2022-03-31 | $14M | 503k | 26.99 |
| 2021-12-31 | $11M | 503k | 22.53 |
| 2021-09-30 | $12M | 473k | 26.21 |
| 2021-06-30 | $14M | 450k | 32.01 |
| 2021-03-31 | $16M | 451k | 35.21 |
| 2020-12-31 | $15M | 452k | 32.07 |
| 2020-09-30 | $17M | 455k | 37.62 |
| 2020-06-30 | $20M | 454k | 44.75 |
| 2020-03-31 | $15M | 426k | 34.11 |
| 2019-12-31 | $14M | 367k | 39.00 |
More positions owned by Parsons Capital Management
View all positions for Parsons Capital Management